Furthermore, a potential role of COMP as an arthritogenic target in RA is derived from clinical studies, where COMP fragments [45,46] and antibody response to COMP [47] have been observed in the serum samples and joint fluids. This evidence concerns the gene COMP and rheumatoid arthritis.